291 related articles for article (PubMed ID: 12060400)
21. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
22. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
23. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?
de Vries E; Soerjomataram I; Houterman S; Louwman MW; Coebergh JW
Am J Epidemiol; 2007 Apr; 165(8):966-72. PubMed ID: 17255116
[TBL] [Abstract][Full Text] [Related]
24. PUVA and skin cancer. A historical cohort study on 492 patients.
Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
[TBL] [Abstract][Full Text] [Related]
25. Re: Nonmelanoma skin cancer and risk for subsequent malignancy.
Grant WB
J Natl Cancer Inst; 2009 Feb; 101(3):210; author reply 210-1. PubMed ID: 19176462
[No Abstract] [Full Text] [Related]
26. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
27. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
[TBL] [Abstract][Full Text] [Related]
28. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
29. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
30. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.
Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK
JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570
[TBL] [Abstract][Full Text] [Related]
31. Psoriasis and susceptibility to nonmelanoma skin cancer.
Stern RS; Scotto J; Fears TR
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):67-73. PubMed ID: 3980806
[TBL] [Abstract][Full Text] [Related]
32. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
Dai H; Li WQ; Qureshi AA; Han J
J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
[TBL] [Abstract][Full Text] [Related]
33. Incidence of invasive cancers following squamous cell skin cancer.
Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
[TBL] [Abstract][Full Text] [Related]
34. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
35. Risk of skin cancer in patients with pterygium: a nationwide population-based cohort study in Taiwan.
Yu HC; Lin CL; Chen ZT; Hu FR; Sung FC; Wang IJ
Ocul Surf; 2014 Jan; 12(1):69-76. PubMed ID: 24439048
[TBL] [Abstract][Full Text] [Related]
36. Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.
Raaschou P; Simard JF; Asker Hagelberg C; Askling J;
BMJ; 2016 Jan; 352():i262. PubMed ID: 26823527
[TBL] [Abstract][Full Text] [Related]
37. Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota.
Brewer JD; Shanafelt TD; Khezri F; Sosa Seda IM; Zubair AS; Baum CL; Arpey CJ; Cerhan JR; Call TG; Roenigk RK; Smith CY; Weaver AL; Otley CC
J Am Acad Dermatol; 2015 Feb; 72(2):302-9. PubMed ID: 25479909
[TBL] [Abstract][Full Text] [Related]
38. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
[TBL] [Abstract][Full Text] [Related]
39. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
40. Association between Use of Hydrochlorothiazide and Risk of Keratinocyte Cancers in Kidney Transplant Recipients.
Letellier T; Leborgne F; Kerleau C; Gaultier A; Dantal J; Ville S;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1804-1813. PubMed ID: 33172936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
